Biomarker Assessment of Glutamatergic Target Engagement

NCT02134951 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Healthy Controls

Interventions

DRUG: Ketamine
DRUG: Normal saline

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]